Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GTx logo — Innovative and passionate experts providing advanced medicin...

GTx

Innovative and passionate experts providing advanced medicines through proven methods.

Founded 1997 Post-IPO Equity Total: $163.18M Biopharma, Biotechnology +1

General Information

Company Name GTx
Founded Year 1997
Founders / Decision Makers
Team member
Industries Biopharma, Biotechnology, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with GTx. To contact GTx, visit gtxinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About GTx

GTx is a biopharma and biotechnology startup that has been revolutionizing the health care industry since its establishment in 1997. With the slogan "Innovative and passionate experts providing advanced medicines through proven methods," GTx, Inc. is committed to delivering better medicines with new science through established pathways. The company recently received a significant $48.50M Post-IPO Equity investment on 26 September 2017, with notable investors including Abingworth, Aisling Capital, Boxer Capital, Amzak Health, and CAM Capital. This investment signifies strong support and confidence in GTx's innovative approach and groundbreaking solutions in the healthcare sector.

Taxonomy: pharmaceuticals, medicine, innovation, medical research, drug development, science, advanced therapies, biomedical engineering

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $48.50M 5
Abingworth Aisling Capital Boxer Capital
Abingworth, Aisling Capital +3
26 Sep 2017
Post IPO Equity $43.41M 1
Biotechnology Value Fund
24 Nov 2014
Post IPO Equity $21.27M -
06 Mar 2014
Post IPO Equity $30.00M -
10 Jan 2008
Series E $20.00M 3
MB Venture Partners Oracle
MB Venture Partners, Oracle +1
20 Aug 2003

GTx Alternatives & Competitors

View All Alternatives
GTx vs
Kayothera
Kayothera United States

Drugging the Undruggable with 1st-in-class RAR/RXR Nuclear Receptor Pathway Inhibitors. EFL Life Sci...

Series A
5 employees
Biotechnology, Health Care
GTx vs
Chimeron Bio
Chimeron Bio United States

Redefining genetic medicine with future-forward RNA technology designed to deliver meaningful patien...

Angel
12 employees
Biotechnology, Health Care
GTx vs
Inoviv
Inoviv United Kingdom

Accelerating the Development of New Medicines with Targeted Proteomics

Venture round
34 employees
Biopharma, Biotechnology
View all alternatives

FAQ About GTx

Innovative and passionate experts providing advanced medicines through proven methods.
GTx was founded in 1997.
GTx operates in Biopharma, Biotechnology and Health Care. Its work centres on pharmaceuticals, medicine, innovation and medical research.
GTx has completed 5 funding rounds, raising a total of $163.18M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to GTx include Kayothera, Chimeron Bio, Inoviv, Second Genome Inc., SonoThera. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GTx and Kayothera are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GTx, https://bouncewatch.com/company/gtx, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes